24 September 2026

 

A mouse without most of its cerebral cortex sounds unlikely to get very far. Yet the mice in a Stanford laboratory could walk around, explore and respond to their surroundings. Only closer testing revealed problems with fine coordination and memory.

The researchers had bred the animals this way for a reason. The cortex, the brain’s outer layer, normally occupies much of the space inside a mouse’s skull. With most of it absent from early development, there was room to try something unusual: transplanting human brain tissue grown in a laboratory.

The tissue survived and expanded. Its neurons sent fibres into the mouse nervous system, and researchers recorded organised activity across the graft while the animals were awake. The study, published in Nature on 16 September, offers a way to watch developing human nerve cells inside a living brain.

 

Brain tissue from a skin cell

 

The transplanted tissue did not come from a person’s brain. Researchers started with donated human cells, reprogrammed them into stem cells and guided them to form small, self-organising clusters resembling parts of the developing cerebral cortex. These clusters are called human cortical organoids.

Brain organoids have become valuable tools for studying human development. Scientists can grow one from someone carrying a particular genetic condition and follow what happens as its cells become neurons. But a cluster in a dish has no normal blood supply or wider nervous system to connect with. Some kinds of brain cell are difficult to produce there.

Transplantation offers the cells a more complex place to grow. Stanford researchers had previously placed human cortical organoids in young rats and found that the neurons matured and connected with the animals’ circuits. There was a constraint, though: the rat’s own cortex was growing in the same space. Its neurons also developed faster than the human ones, giving them a head start in making connections.

The new mice gave the human tissue far less competition.

 

Making room for human neurons

 

The team bred mice in which most of the cortex and hippocampus did not develop. The animals were viable, even though these brain regions are involved in functions including movement and memory. Other parts of the nervous system may have compensated for some of what was missing, although behavioural tests showed that the loss was not without effect.

Soon after birth, the mice received human cortical organoids in the space left behind. Over the following months, the grafts grew to occupy most of the available cortical volume. Human neurons extended fibres into other parts of the brain and towards the spinal cord. Recordings showed bursts of activity across the tissue, resembling patterns in developing neural circuits.

The researchers also found cells resembling von Economo neurons. These distinctive cells have been difficult to produce in organoids kept in a dish. In humans, they are found in particular cortical regions and are affected in some forms of frontotemporal dementia. Finding similar cells in the grafts gives scientists a chance to investigate how they develop and, eventually, how disease might affect them.

What about the mice? Those carrying grafts could move around and explore, although testing found some differences in coordination and spontaneous behaviour. It would be tempting to attribute an action to the human neurons. The study cannot yet do that: behaviour arises from the graft interacting with the mouse’s remaining nervous system, and the researchers have not established which actions require the transplanted cells.

They could, however, see what happened when those cells were injured.

 

What happens when oxygen runs low

 

A shortage of oxygen around birth can damage a developing human brain. Mouse studies can help investigate such injuries, but a mouse cell may not respond in precisely the same way as a human one.

To demonstrate what their model could reveal, the Stanford team exposed some of the animals to low oxygen. Afterwards, they detected a pronounced injury response in the human grafts that was not apparent in nearby mouse cortical tissue under the conditions tested. The mice carrying grafts also developed measurable difficulties with their gait; mice without grafts did not show the same response in this experiment.

That combination is valuable. Researchers could examine a response in developing human cells and measure a change in a living animal. It may help them investigate aspects of brain injury linked to oxygen deprivation around birth, including those relevant to cerebral palsy.

The experiment does not reproduce that condition in full or point to a treatment. The team also sees possible uses in research on epilepsy, autism and schizophrenia, but those questions still need their own tests.

 

How would we know if a mouse had changed?

 

The scientific possibilities come with a difficult responsibility. As grafts grow larger or more mature, how should researchers assess their effects on the animals carrying them?

Movement, memory, responses to stimuli and signs of distress can all be tested. The harder part is deciding what else to look for as the tissue develops. In this study, the mice’s wellbeing was monitored and their behaviour assessed. The work received animal and stem-cell research approvals, alongside advice from ethicists and an external committee. The authors recommend continued ethical scrutiny of future experiments.

There are scientific limits too. The grafts remained immature and lacked some of the organised structure of a developing human cortex. An independent expert cautioned that connections and electrical activity do not, by themselves, show that the transplanted cells perform the same functions they would in a human brain.

Still, the achievement is striking. Human neurons grew in a living nervous system, produced cells rarely seen in laboratory organoids and showed a measurable response to injury. The mice made that view possible. Understanding what the experiment means for them will have to advance alongside the science.